Embla Medical Statistics

Total Valuation

Embla Medical has a market cap or net worth of DKK 14.73 billion. The enterprise value is 17.82 billion.

Market Cap	14.73B
Enterprise Value	17.82B

Important Dates

The next estimated earnings date is Wednesday, February 5, 2025.

Earnings Date	Feb 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Embla Medical has 426.93 million shares outstanding. The number of shares has increased by 0.69% in one year.

Current Share Class	n/a
Shares Outstanding	426.93M
Shares Change (YoY)	+0.69%
Shares Change (QoQ)	+1.00%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	83.59%
Float	158.65M

Valuation Ratios

The trailing PE ratio is 31.94 and the forward PE ratio is 23.12. Embla Medical's PEG ratio is 1.96.

PE Ratio	31.94
Forward PE	23.12
PS Ratio	2.63
PB Ratio	2.81
P/TBV Ratio	n/a
P/FCF Ratio	24.07
P/OCF Ratio	n/a
PEG Ratio	1.96

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.33, with an EV/FCF ratio of 29.13.

EV / Earnings	38.60
EV / Sales	3.17
EV / EBITDA	17.33
EV / EBIT	23.97
EV / FCF	29.13

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.69.

Current Ratio	1.99
Quick Ratio	1.05
Debt / Equity	0.69
Debt / EBITDA	3.64
Debt / FCF	5.91
Interest Coverage	4.99

Financial Efficiency

Return on equity (ROE) is 9.49% and return on invested capital (ROIC) is 5.39%.

Return on Equity (ROE)	9.49%
Return on Assets (ROA)	4.54%
Return on Capital (ROIC)	5.39%
Revenue Per Employee	1.40M
Profits Per Employee	115,446
Employee Count	3,999
Asset Turnover	0.58
Inventory Turnover	2.23

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.46% in the last 52 weeks. The beta is 0.62, so Embla Medical's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+25.46%
50-Day Moving Average	35.37
200-Day Moving Average	31.52
Relative Strength Index (RSI)	39.90
Average Volume (20 Days)	120,761

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Embla Medical had revenue of DKK 5.62 billion and earned 461.79 million in profits. Earnings per share was 1.08.

Revenue	5.62B
Gross Profit	3.48B
Operating Income	709.60M
Pretax Income	600.74M
Net Income	461.79M
EBITDA	832.49M
EBIT	709.60M
Earnings Per Share (EPS)	1.08

Full Income Statement

Balance Sheet

The company has 542.96 million in cash and 3.62 billion in debt, giving a net cash position of -3.07 billion or -7.20 per share.

Cash & Cash Equivalents	542.96M
Total Debt	3.62B
Net Cash	-3.07B
Net Cash Per Share	-7.20
Equity (Book Value)	5.26B
Book Value Per Share	12.27
Working Capital	1.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 741.43 million and capital expenditures -129.60 million, giving a free cash flow of 611.84 million.

Operating Cash Flow	741.43M
Capital Expenditures	-129.60M
Free Cash Flow	611.84M
FCF Per Share	1.43

Full Cash Flow Statement

Margins

Gross margin is 62.02%, with operating and profit margins of 12.63% and 8.22%.

Gross Margin	62.02%
Operating Margin	12.63%
Pretax Margin	10.69%
Profit Margin	8.22%
EBITDA Margin	14.82%
EBIT Margin	12.63%
FCF Margin	10.89%

Dividends & Yields

Embla Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.69%
Shareholder Yield	-0.69%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Embla Medical has an Altman Z-Score of 2.95. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.95
Piotroski F-Score	n/a